Skip to main content
. 2013 Apr 30;65(2):183–191. doi: 10.3138/ptc.2012-23O

Table 1.

Baseline Subject Characteristics by Study Site

No. (%) of patients*
Characteristics Site A (experimental) (n=41) Site B (comparison) (n=31) p-value
Demographic data, mean (SD)
 Age, y 55.1 (14.8) 62.8 (14.1) 0.03
 BMI, kg/m2 27.1 (5.4) 27.0 (4.2) 0.96
 Lymph nodes dissected, no. 7.6 (6.3) 9.7 (6.3) 0.16
 Lymph nodes positive, no. 1.8 (4.2) 1.4 (3.7) 0.66
Cancer stage
 DCIS or Stage 1 2 (4.9) 2 (6.5) 0.94
 Stage II 14 (34.1) 10 (32.2)
 Stage III 19 (46.3) 13 (41.9)
 Unknown 6 (14.6) 6 (19.4)
Surgery type
 Modified radical mastectomy 22 (53.7) 7 (22.6) 0.03
 Simple mastectomy 7 (17.1) 9 (29.0)
 Breast conserving 12 (29.3) 15 (48.4)
 Previous breast surgery 9 (22.0) 6 (19.4) 0.79
Treatment
 Reconstruction 22 (53.7) 3 (9.7) <0.01
 Adjuvant radiation 22 (53.7) 14 (45.2) 0.48
 Adjuvant chemotherapy 16 (39) 16 (32.3) 0.55
Muscular strength (MMT)
 Shoulder abduction
  <5

11 (26.8)

6 (19.4%)

0.46
  5 30 (73.2) 25 (80.6%)
 Shoulder flexion
  <5

10 (24.4)

3 (9.7%)

0.11
  5 31 (75.6) 28 (90.3%)
 Shoulder external rotation
  <5

11 (26.8)

5 (16.1%)

0.28
  5 30 (73.2) 26 (83.9%)
 Elbow flexion
  <5

10 (24.4)

4 (12.9%)

0.22
  5 31 (75.6) 27 (87.1%)
Risk factors for lymphedema
 Presence of >1 risk factor 19 (46.3) 15 (48.4) 0.85
 >5 nodes dissected 22 (53.7) 23 (74.2) 0.08
 Postoperative infection 4 (9.8) 2 (6.5) 0.62
 Radiation 22 (53.7) 14 (45.2) 0.48
 BMI >30 8 (19.5) 6 (19.4) 0.99
 Preoperative pain 3 (7.3) 3 (9.7) 0.72
*

Unless otherwise specified.

Based on independent samples t-test for continuous variables and chi-square tests for categorical variables.

Either another primary on same side or second surgery for same cancer diagnosis (e.g., modified mastectomy following lumpectomy).

BMI=body mass index; DCIS=ductal carcinoma in situ; MMT=manual muscle testing.